Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Bayesian reassessment of the epigenetic architecture of complex traits.

Nature communications | 2020

Linking epigenetic marks to clinical outcomes improves insight into molecular processes, disease prediction, and therapeutic target identification. Here, a statistical approach is presented to infer the epigenetic architecture of complex disease, determine the variation captured by epigenetic effects, and estimate phenotype-epigenetic probe associations jointly. Implicitly adjusting for probe correlations, data structure (cell-count or relatedness), and single-nucleotide polymorphism (SNP) marker effects, improves association estimates and in 9,448 individuals, 75.7% (95% CI 71.70-79.3) of body mass index (BMI) variation and 45.6% (95% CI 37.3-51.9) of cigarette consumption variation was captured by whole blood methylation array data. Pathway-linked probes of blood cholesterol, lipid transport and sterol metabolism for BMI, and xenobiotic stimuli response for smoking, showed >1.5 times larger associations with >95% posterior inclusion probability. Prediction accuracy improved by 28.7% for BMI and 10.2% for smoking over a LASSO model, with age-, and tissue-specificity, implying associations are a phenotypic consequence rather than causal.

Pubmed ID: 32513961 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: MR/K026992/1
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/S020845/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_19009
  • Agency: Wellcome Trust, United Kingdom
    Id: 104036/Z/14/Z
  • Agency: Chief Scientist Office, United Kingdom
    Id: CZD/16/6
  • Agency: Department of Health, United Kingdom
  • Agency: Medical Research Council, United Kingdom
    Id: G0700704
  • Agency: Medical Research Council, United Kingdom
    Id: MR/M01311/1
  • Agency: Wellcome Trust, United Kingdom
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/I025263/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12013/2
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/I025751/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_00011/5
  • Agency: Wellcome Trust, United Kingdom
    Id: 208806/Z/17/Z
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_15018
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_U127592696
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_00007/10

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GenomeStudio (tool)

RRID:SCR_010973

Visualize and analyze data generated by all of Illumina''s platforms.

View all literature mentions

Accessible Resource for Integrated Epigenomics Studies (tool)

RRID:SCR_017492

Portal for epigenomic information on range of human tissues, including DNA methylation data on peripheral blood at multiple time points across lifecourse. Provides web interface to browse methylation variation between groups of individuals and across time.

View all literature mentions